The global Laboratory Andrology Equipment Market is projected to grow from USD 1.0 billion in 2026 to USD 1.6 billion by 2036, expanding at a 5.1% CAGR during the forecast period, according to Fact.MR. The market reached USD 1.0 billion in 2025.
The market is expected to gain USD 0.6 billion in absolute opportunity between 2026 and 2036 as hospitals, fertility centers, and diagnostic laboratories strengthen semen testing, sample preparation, warming, preservation and quality-control workflows.
Demand is closely linked to the need for consistent semen assessment. Fertility clinics require repeatable measurements of sperm concentration, motility and morphology, while laboratories increasingly use computer-assisted systems to reduce operator variation during sample analysis.
Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=5691
Standardized Semen Testing Supports Market Growth
Infertility creates a sustained need for reproductive diagnostic services. The World Health Organization stated in November 2025 that infertility affects about one in six people of reproductive age worldwide during their lifetime.
Within male fertility assessment, routine semen analysis remains an important starting point. Laboratories need equipment capable of producing documented and repeatable measurements as samples move from collection through analysis and reporting.
Computer-assisted semen analysis, or CASA, is also gaining relevance within laboratory workflows. Equipment providers are developing systems that support analysis of sperm concentration, motility, morphology and additional sperm characteristics.
Quality control is another consideration. Laboratories handling repeat semen testing require validation procedures and documented controls to support consistency between tests and across operators.
Semen Analysis Equipment Leads the Product Segment
Semen Analysis Equipment is projected to account for 33.60% of the market in 2026, making it the leading product category.
Its position is linked to the central role of concentration, motility and morphology measurements in male-factor infertility assessment. CASA platforms can provide automated analysis and help laboratories standardize measurement workflows.
Specialized systems can extend analysis into areas such as DNA fragmentation, vitality, acrosome reaction and other sperm-function parameters. However, routine semen assessment remains a core laboratory requirement.
Routine Semen Analysis is expected to lead the testing segment with a 35.90% share in 2026. It provides the baseline assessment used during initial male fertility evaluation, repeat testing and treatment planning.
Hospitals Remain the Largest End User
Hospitals are anticipated to represent 56.90% of the market in 2026.
Hospital reproductive medicine departments often combine diagnostic testing with specialist consultations and assisted reproductive technology workflows. Their laboratories therefore require reliable throughput for time-sensitive semen samples.
Demand extends beyond analyzers. Hospitals and fertility laboratories may require sample preparation equipment, warming systems, controlled laboratory environments and cryopreservation infrastructure.
The broader workflow creates opportunities for suppliers that can provide equipment, documentation, service support and training across laboratory and clinical interfaces.
United States Records the Highest Listed Country CAGR
The United States is projected to record a 5.5% CAGR from 2026 to 2036. Demand is supported by hospital fertility services and standardized semen testing.
Germany follows with a projected 5.1% CAGR, while Japan is expected to advance at 4.8% CAGR. France and Italy are projected to record CAGRs of 4.4% and 3.9%, respectively.
The differences reflect variations in fertility-care activity, clinic networks, laboratory documentation, reproductive medicine workflows and demand for preservation and sample-handling services.
Equipment Providers Focus on Workflow and Measurement
The competitive landscape includes Nexpring Health through Hamilton Thorne and Microptic, Medical Electronic Systems LLC, Shivani Scientific Industries Pvt. Ltd., Thermo Fisher Scientific Inc., and ZEISS.
Competitive differentiation is expected to center on analyzer performance, preanalytical workflow documentation, service support and integration with time-sensitive semen-testing processes.
Hamilton Thorne and Microptic provide CASA-related platforms and software covering areas including sperm concentration, motility, morphology and specialized sperm-function measurements. Medical Electronic Systems supplies automated semen-analysis systems, testing supplies and validation kits.
Other suppliers contribute equipment supporting controlled laboratory environments, microscopy, sample handling and reproductive laboratory workflows.
Market Opportunities and Constraints
The report identifies several opportunities for industry participants. CASA upgrades for routine laboratories represent an opportunity, alongside integrated preparation and warming systems and cryopreservation workflow support.
At the same time, fertility-care coverage and eligibility limitations can affect adoption. Training requirements and dependence on manual skills remain considerations in lower-volume laboratories, while capital costs can constrain investment in automated analyzer systems.
As reproductive laboratories seek greater consistency, equipment vendors may need to demonstrate analyzer performance, support quality-control programs and provide documentation suited to regulated clinical workflows.
Shambhu Nath Jha, Principal Consultant at Fact.MR, states: “Andrology equipment is drawing attention because semen testing remains sensitive to timing, temperature and operator technique. Demand is expected to move toward systems that document sample handling and produce repeatable measurements.”
Report Scope
The Laboratory Andrology Equipment Market assessment covers equipment used to examine, prepare, warm, handle and preserve semen samples across hospitals, fertility centers, andrology laboratories, clinical laboratories and reproductive medicine departments.
The study analyzes the market by:
- Product: Semen Analysis Equipment; Andrology Sample Preparation Equipment; Sample Collection and Handling Equipment; Temperature Control Equipment; Cryopreservation Equipment
- Testing: Routine Semen Analysis; Specialized Semen Testing; Sperm Function Testing; Sperm Preservation and Processing
- End User: Hospitals; Andrology Laboratories; Clinical Laboratories; Outpatient Facilities
- Regions: North America; Latin America; Western Europe; Eastern Europe; East Asia; South Asia & Pacific; Middle East & Africa
- Forecast Period: 2026–2036
The analysis draws on more than 120 sources, 35 company portfolios, 25 countries and more than 20 industry interviews.
Top Trending Reports:
Automotive Wrap Films Market Forecast 2026-2036: Global Market to Reach USD 2.7 Bn by 2035 at ~ 5.3 % CAGR
High-Heat Epoxy Films Market Forecast 2026-2036: Global Market to Reach USD 3.4 Bn by 2035 at ~ 9.0 % CAGR
About (FACT MR)
Future Market Insights (FACT MR) provides market intelligence and research covering industries, technologies, products and evolving business opportunities. Its research combines primary interviews, desk research, market sizing, forecasting and data validation to help organizations understand market developments and emerging demand patterns.
